Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 41, 2017 - Issue 2
119
Views
5
CrossRef citations to date
0
Altmetric
Short Communication

New Insights on β-Thalassemia in the Palestinian Population of Gaza: High Frequency and Milder Phenotype Among Homozygous IVS-I-1 (HBB: c.92+1G>A) Patients with High Levels of Hb F

, , , &
Pages 144-146 | Received 04 Feb 2017, Accepted 22 Apr 2017, Published online: 03 Jul 2017

References

  • Mahdieh N, Rabbani B. β Thalassemia in 31,734 cases with HBB gene mutations: pathogenic and structural analysis of the common mutations; Iran as the crossroads of the Middle East. Blood Rev. 2016;30(6):493–508.
  • Filon D, Oron V, Krichevski S, et al. Diversity of β-globin mutations in Israeli ethnic-groups reflects recent historic events. Am J Hum Genet. 1994;54(5):836–843.
  • Filon D, Oron V, Shawa R, et al. Spectrum of β-thalassemia mutations in the Gaza area. Hum Mutat. 1995;5(5):351–353.
  • Ayesh SK, Al-Sharef WA, Nassar SM, et al. Prenatal diagnosis of β-thalassemia in the West Bank and Gaza. Saudi Med J. 2005;26(11):1771–1776.
  • Hamamy H, Al-Allawi N. Epidemiological profile of common haemoglobinopathies in Arab countries. J Community Genet. 2013;4(2):147–167.
  • Reading NS, Sirdah MM, Tarazi IS, Prchal JT. Detection of nine Mediterranean β-thalassemia mutations in Palestinians using three restriction enzyme digest panels: a reliable method for developing countries. Hemoglobin. 2014;38(1):39–43.
  • Rund D, Dowling C, Najjar K, et al. Two mutations in the β-globin polyadenylylation signal reveal extended transcripts and new RNA polyadenylylation sites. Proc Natl Acad Sci USA. 1992;89(10):4324–4328.
  • Jassim N, Merghoub T, Pascaud O, et al. Molecular basis of β-thalassemia in Bahrain: an epicenter for a middle east specific mutation. Cooleys Anemia: Seventh Symposium. Ann NY Acad Sci. 1998;850:407–409.
  • Elhazmi MAF. Xmn-I polymorphism in the γ-globin gene region among Saudis. Hum Hered. 1989;39(1):12–19.
  • Gambari R, Fibach E. Medicinal chemistry of fetal hemoglobin inducers for treatment of β-thalassemia. Curr Med Chem. 2007;14(2):199–212.
  • Kyriacou K, Al Quobaili F, Pavlou E, et al. Molecular characterization of β-thalassemia in Syria. Hemoglobin. 2000;24(1):1–13.
  • Chehab FF, Derkaloustian V, Khouri FP, et al. The molecular-basis of β-thalassemia in Lebanon – Application to prenatal-diagnosis. Blood. 1987;69(4):1141–1145.
  • Sadiq MFG, Huisman THJ. Characterization of β-thalassemia in North Jordan. Hemoglobin. 1994;18(4-5):325–332.
  • Hussein IR, Temtamy SA, Elbeshlawy A, et al. Molecular characterization of β-thalassemia in Egyptians. Hum Mutat. 1993;2(1):48–52.
  • Abd El-Latif M, Filon D, Rund D, et al. The β+-IVS-I-6 (T→C) mutation accounts for half of the thalassemia chromosomes in the Palestinian populations of the mountain regions. Hemoglobin. 2002;26(1):33–40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.